DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment

Phase 2

Completed

Conditions: Opioid-use Disorder

Interventions: Drug: Lofexidine 0.18 MG

First Posted Date: 2019-08-14

Last Posted Date: 2021-12-09

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 20

Registration Number: NCT04056182

Locations: 🇺🇸
STARS/NYSPI-Columbia University, New York, New York, United States

OnTrackNY's Learning Healthcare System

Suspended

Conditions: First Episode Psychosis

Interventions: Other: Stakeholder feedback
Other: Data infrastructure

First Posted Date: 2019-07-16

Last Posted Date: 2025-01-31

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 2100

Registration Number: NCT04021719

Locations: 🇺🇸
OnTrackNY Central, New York, New York, United States

Cognitive Remediation for Coordinated Specialty Care

Not Applicable

Suspended

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Behavioral: Partial-Remote Cognitive Remediation
Behavioral: Clinic-Based Cognitive Remediation

First Posted Date: 2019-04-29

Last Posted Date: 2025-05-21

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 117

Registration Number: NCT03930251

Locations: 🇺🇸
Staten Island University Hospital, Staten Island, New York, United States
🇺🇸
The Institute for Family Health, Bronx, New York, United States
🇺🇸
Bellevue Hospital Center, New York, New York, United States

and more 6 locations

18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder

Phase 4

Completed

Conditions: Bipolar Depression

Interventions: Drug: Lurasidone

First Posted Date: 2019-04-04

Last Posted Date: 2023-11-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 1

Registration Number: NCT03902613

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Development of Novel Measures for Alzheimer's Disease Prevention Trials

Not Applicable

Suspended

Conditions: Healthy Participants

Interventions: Other: Preclinical Alzheimer's Cognitive Composite (PACC), Alzheimer's Disease Assessment Scale-Cognitive Scale (ADAS-Cog), and Functional Assessment Questionnaire (FAQ)
Other: No Practice Effects (NPE) cognitive battery, and Miami Computerized Functional Assessment Scale (CFAS)

First Posted Date: 2019-04-03

Last Posted Date: 2025-05-18

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 400

Registration Number: NCT03900273

Locations: 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
The Feinstein Institute for Medical Research, Manhasset, New York, United States
🇺🇸
University of Southern California, Los Angeles, California, United States

and more 1 locations

An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder

Phase 1

Completed

Conditions: Opioid-use Disorder

Interventions: Drug: Sublocade

First Posted Date: 2019-03-04

Last Posted Date: 2021-03-09

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 11

Registration Number: NCT03861338

Locations: 🇺🇸
Substance Treatment Research Service (STARS) of Columbia University, New York, New York, United States

ITI-007 (Lumateperone Tosylate) for Schizophrenia

Phase 2

Terminated

Conditions: Schizophrenia

Interventions: Drug: ITI-007

First Posted Date: 2019-01-25

Last Posted Date: 2021-11-04

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 4

Registration Number: NCT03817528

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Contact: Developing New Clinical Management Strategies

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Placebo
Drug: Escitalopram

First Posted Date: 2019-01-23

Last Posted Date: 2022-04-21

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 29

Registration Number: NCT03812588

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

The Effect of rTMS to the Prefrontal Cortex in Alcohol Use Disorder

Not Applicable

Suspended

Conditions: Alcohol Use Disorder

Interventions: Behavioral: Inpatient admission
Device: active rTMS
Device: sham rTMS

First Posted Date: 2019-01-18

Last Posted Date: 2025-05-14

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 44

Registration Number: NCT03809286

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

IPT-A for Adolescents With PTSD Symptoms

Not Applicable

Completed

Conditions: PTSD

Interventions: Behavioral: Interpersonal Psychotherapy for Adolescents

First Posted Date: 2019-01-08

Last Posted Date: 2024-02-02

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 9

Registration Number: NCT03795818

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy